LONDON, UK: Apollon Formularies plc (AQSE: APOL), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, is advancing an application to join the OTCQB Market (“OTCQB”) in the United States. Apollon’s Ordinary Shares will continue to trade on the Aquis Stock Exchange under the symbol APOL. The Company decided to undertake this…